<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01309152</url>
  </required_header>
  <id_info>
    <org_study_id>MICK R-10.29A/MICK</org_study_id>
    <secondary_id>LTME/VL-10.14/MICK</secondary_id>
    <nct_id>NCT01309152</nct_id>
  </id_info>
  <brief_title>Cefazolin Subcutaneous Microdialysis in Morbidly Obese Patients</brief_title>
  <acronym>MICK</acronym>
  <official_title>Peri-and Postoperative Subcutaneous Adipose Tissue Cefazolin Determination Using Microdialysis in Morbidly Obese and Non-obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that cefazolin perfusion to subcutaneous adipose tissue is
      reduced in morbidly obese patients. The primary objective of this exploratory pilot study is
      therefore to investigate target site (subcutaneous adipose tissue) penetration of cefazolin
      in morbidly obese patients and non-obese patients. The investigators aim to examine whether
      and how cefazolin plasma concentrations are predictive of subcutaneous (target) cefazolin
      concentrations. Possible factors of influence on the distribution of cefazolin (tissue
      perfusion, body weight, distribution of adipose tissue, other) will be identified.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">16</enrollment>
  <condition>Morbid Obesity</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and microdialysis filtrate of subcutenous tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        8 morbidly obese patients undergoing weight reducing surgery And 8 non-obese patients
        undergoing surgery which will require an arterial line, nadroparin and cefazolin
        administration perioperatively and postoperative stay at the Post-Anesthesia Care Unit.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index &gt; 40 kg/m2

          -  BMI between 20-25

          -  undergoing laparoscopic gastric banding, or bypass surgery or sleeve gastrectomy (See
             population description for surgery type of the non-obese group)

          -  21-60 years old

          -  American Society of Anaesthesiologists (ASA) physical status II to III

        Exclusion Criteria:

          -  pregnancy

          -  breastfeeding

          -  known allergy for cefazolin/nadroparin

          -  known ejection fraction of &lt; 35%

          -  renal insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>2500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. antonius hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2011</study_first_submitted>
  <study_first_submitted_qc>March 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2011</study_first_posted>
  <last_update_submitted>January 2, 2013</last_update_submitted>
  <last_update_submitted_qc>January 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 3, 2013</last_update_posted>
  <responsible_party>
    <name_title>CAJ Knibbe</name_title>
    <organization>St. Antonius Hospital</organization>
  </responsible_party>
  <keyword>cefazolin</keyword>
  <keyword>microdialysis</keyword>
  <keyword>morbid obesity</keyword>
  <keyword>pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cefazolin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

